Can Spravato (esketamine) be taken at home?
Spravato is designed to be used under a restricted program rather than taken freely at home. Patients generally must receive it through a certified healthcare setting (for example, an outpatient clinic) where they can be monitored during and after dosing because Spravato can cause sedation and other short-term effects.
What monitoring is required if Spravato is used outside a clinic?
Because Spravato can impair alertness and judgment, the prescribing and dispensing model requires observation after each dose. This is part of why it is not treated like a standard at-home medicine—patients need supervised use and post-dose monitoring for safety.
Why isn’t Spravato approved for unsupervised home use?
Spravato (esketamine) acts on the brain and can cause acute, short-term side effects (including dissociation, dizziness, sedation, and blood pressure changes). The home-use concern is that these effects may make it unsafe to drive or make decisions without medical supervision.
Are there any exceptions or special home-use programs?
The available information here points to a supervised, restricted-use model rather than routine at-home dosing. Specific programs, eligibility rules, or provider arrangements can vary by location and treatment plan, but unsupervised home administration is not the standard approach.
What should patients do if they’re asking about home dosing?
Patients who want a more convenient plan should ask their prescriber or the Spravato treatment center about logistics (travel, scheduling, and clinic requirements). The key question to confirm with the treatment site is whether they can administer Spravato only at their facility and what the required observation time and safety steps are.
Sources